That is not quite correct @DTshares. Whilst the statement "the patient needs a health Tcell count/immune system" may have been a red flag for you, anyone paying attention would know the immune system is involved in the CF33 methods of action and therefore would expect a healthy immune system would produce better efficacy.
As one example, here's a slide from the Imugene Investor Presentation from November 2023. I have highlighted the specific dot points about immune response.
If you want to know more about the expected increase of CD8+ T cells, have a read in this article:
That is not quite correct @DTshares. Whilst the statement "the...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
-0.003(2.94%) |
Mkt cap ! $614.8M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.195M | 14.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5654 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 4294 | 3 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |